Next-Generation CAR-T Therapy Shows Promise in Child’s Neuroblastoma
Cell Medica’s next-generation CAR-T cell therapy has resulted in 'extensive tumor regression' in a…
Cell Medica’s next-generation CAR-T cell therapy has resulted in 'extensive tumor regression' in a…
The French company OSE Immunotherapeutics has signed a partnership to use artificial intelligence to develop…
The positive stance of the UK Government towards incorporation of genomics into healthcare has created…
Using artificial intelligence, a Belgian research group can diagnose juvenile arthritis from blood samples with…
SNIPR Biome has raised €43M in Series A funds to develop treatments that precisely target…
The investment will fund a program to sequence the genome of 400,000 Irish people and…
Genetically-edited organisms that were until now excluded from GMO regulation will now be subject to…